Sinecod SR-50

Indications of Sinecod SR-50 Tablet

Butamirate Citrate is a cough suppressant that is used to treat dry (non-productive) cough. A recent viral illness could be the source of your dry cough. Butamirate Citrate is also utilized for cough sedation prior to and after surgical procedures and bronchoscopy in patients. It can be used for any type of acute cough, including whooping cough and cough caused by acute lower respiratory tract infections (tracheitis, laryngitis, bronchitis), among other things.

 

Pharmacology of Sinecod SR-50 Tablet

Butamirate Citrate suppresses cough by acting directly on the cough area in the brain. Butamirate Citrate is a non-sedating, non-toxic substance that is not connected to opium alkaloids chemically or pharmacologically. After oral treatment, butamirate citrate is swiftly and completely absorbed. The sustained-release pill reaches maximum concentration in 9 hours. This is highly protein-bound, with a plasma half-life of about 13 hours. Butamirate Citrate's active metabolites also have antitussive properties.

 

Dosage & Administration of Sinecod SR-50 Tablet

Use in adult:

• Butamirate Citrate 50 mg tablet: 2-3 tablets daily.
• Butamirate Citrate syrup: 15 ml 4 times daily.

Use in children & adolescents:

Butamirate Citrate 50 mg tablet:

• Adolescent over 12 years old: 1-2 tablets daily.

Butamirate Citrate syrup:

• Children (3-6 yrs): 5 ml 3 times daily.
• Children (6-12 yrs): 10 ml 3 times daily.
• Adolescent: 15 ml 3 times daily.

Butamirate Citrate pediatric drops:

• Children ( 2 months- 1 yrs): 0.50 ml 4 times daily.
• Children (1-3 yrs): 0.75 ml 4 times daily.

 

Interaction of Sinecod SR-50 Tablet

Concomitant use with expectorants of Sinecod SR-50 Tablet should be avoided.

 

Contraindications

Hypersensitivity to the active ingredient.

 

Side Effects of Sinecod SR-50 Tablet

Tolerance of Butamirate Citrate is good.Adverse reactions such as rash,nausea,diarrhoea and vertigo have been observed in a few rare cases,resolving after dose reduction or treatment withdrawal.

 

Pregnancy & Lactation

During the first trimester of pregnancy, butamirate Citrate should be avoided. It can be used for the rest of the pregnancy if a doctor recommends it, but only with caution. In the absence of data on active substance removal in breast milk, the benefits of Butamirate Citrate administration during breast feeding should be carefully evaluated against the dangers, as a general rule.

 

Precautions & Warnings

Because Butamirate Citrate suppresses the cough reflex, it should not be used in conjunction with expectorants, as this may cause mucus retention in the airways, increasing the risk of bronchospasm and respiratory infections. A doctor should be examined if the cough lasts longer than 7 days (or more than 3 days in children under the age of 12).

 

Therapeutic Class

Cough suppressant

 

Storage Conditions

Keep away from light and moisture, store below 30°C. Keep all the medicines out of the reach of children.

 

Pharmaceutical Name of Sinecod SR-50 Tablet

SANDOZ (A Novartis Division)

 

Generic of Sinecod SR-50 Tablet

Butamirate Citrate